Centre Hospitalier Universitaire Vaudois (CHUV)
Centre Pluridisciplinaire d’Oncologie
Solange Peters, MD, PhD, achieved her MD from the Medical School at the University of Lausanne in 1998, following this she attended the Microbiology Institute at the University of Lausanne until 2002, concluding with a MD-PhD thesis on new HIV drug-resistance mechanisms.
From 2002-2006, Dr Peters did her residency in Internal Medicine, followed by a Fellowship at the Multidisciplinary Oncology Centre, both at the University Hospital of Lausanne. In September 2006 she sat the ESMO Examination in Oncology and was awarded the ESMO Best European Exam result. This was shortly followed by the SSMO (Swiss Society of Medical Oncology) oral exam November 2006. In 2013, Dr Peters received the title of Lausanne University Private Docent (PD-MER).
Dr Peters is currently in charge of teaching and patient care in the area of thoracic malignancies at the Department of Oncology of Lausanne University, where she is building a translational programme in collaboration with the molecular oncology laboratory directed by Dr Hanahan and Prof. E. Meylan and the Ludwig Institute.
Dr Peters’ main field of interest is new biomarker discovery and validation in preclinical and clinical settings. She is also strongly involved and interested in multimodality trial building for locally-advanced NSCLC. Her current research projects are focused on stage III NSCLC multimodal treatment, notably as the Primary Investigator (PI) of the SAKK trial (Swiss Group for Clinical Cancer Research): SAKK 16/08 Preoperative chemotherapy and radiotherapy concomitant to Cetuximab in NSCLC patients with IIIB disease. She acts as the local PI of lung trials opened in Lausanne Cancer Centre, focused on predictive biomarkers and NSCLC immunotherapy. In addition, she is a co-PI of several other trials.
She is co-chair of Swiss Lung Cancer Research group, and responsible for trials organisation and coordination, as well as related databases for the ETOP (European Thoracic Oncology Platform) Lungscape project database (member of the steering committee), where she is responsible for communication as well as scientific coordinator.
Solange Peters is an active member of the educational programme within ESMO and IASLC (International Association for the Study of Lung Cancer), an ESMO Faculty member (2012-2014) and a member of the ESMO E-Learning and CME Working Group. She is a member of AACR (American Association for Cancer Research) and EORTC (European Organisation for Research and Treatment of Cancer).
Of national organisations, Dr Peters is the president of FOROME (Association Romande pour la formation continue en oncologie médicale), board member of SAMO (Swiss Academy for Multidisciplinary Oncology), and member of SAKK (Swiss Group for Clinical Cancer Research), FMH (Association of Swiss Physicians) and ASMAC/VSAO (Association of Swiss Interns and Residents).
Dr Peters was the associate editor of ‘Lung Cancer’ and became Deputy Editor of the ‘Journal of Thoracic Oncology’ (JTO), the official journal of IASLC, in 2013. In addition, she acts as associate editor for ‘Frontiers in Pharmacology of Anti-Cancer Drugs’ and review editor for ‘Frontiers in Thoracic Oncology’. She is the author of numerous articles in peer-reviewed publications as well as book chapters and abstracts and the co-editor of the book "Perspectives in Thoracic Oncology" (UNI-MED) and the book series ‘Progress in Tumor Research’ (Karger)